Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Enrolling by Invitation

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

NCT06773936

Conditions
CD19+ Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • UC Irvine Medical Center Orange, California, United States
  • Northwell Health/Center for Advanced Medicine Lake Success, New York, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Enrolling by Invitation

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

NCT05669989

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Washington University- Site Number : 8400001 St Louis, Missouri, United States
  • Investigational Site Number : 0360006 Blacktown, New South Wales, Australia
  • Investigational Site Number : 0360001 Saint Leonards, New South Wales, Australia
  • Investigational Site Number : 0360003 Wollongong, New South Wales, Australia
View all 37 locations
View Trial Details

Related conditions